{"organizations": [], "uuid": "5ce99241fbb2a106c2e371aa4e5b64e1b5e53f70", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/04/24/the-associated-press-amgen-1q-earnings-snapshot.html", "country": "US", "domain_rank": 767, "title": "Amgen: 1Q Earnings Snapshot", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-25T00:55:00.000+03:00", "replies_count": 0, "uuid": "5ce99241fbb2a106c2e371aa4e5b64e1b5e53f70"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/04/24/the-associated-press-amgen-1q-earnings-snapshot.html", "ord_in_thread": 0, "title": "Amgen: 1Q Earnings Snapshot", "locations": [], "entities": {"persons": [], "locations": [{"name": "thousand oaks", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}], "organizations": [{"name": "amgen inc.", "sentiment": "negative"}, {"name": "amgen", "sentiment": "negative"}, {"name": "amgn", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "standard & poor", "sentiment": "none"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "THOUSAND OAKS, Calif. (AP) _ Amgen Inc. (AMGN) on Tuesday reported first-quarter net income of $2.31 billion.\nThe Thousand Oaks, California-based company said it had net income of $3.25 per share. Earnings, adjusted for non-recurring costs, came to $3.47 per share.\nThe results exceeded Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $3.23 per share.\nThe world's largest biotech drugmaker posted revenue of $5.55 billion in the period, also beating Street forecasts. Eight analysts surveyed by Zacks expected $5.46 billion.\nAmgen expects full-year earnings in the range of $12.80 to $13.70 per share, with revenue in the range of $21.9 billion to $22.8 billion.\nAmgen shares have fallen 1 percent since the beginning of the year, while the Standard & Poor's 500 index has declined 1.5 percent. In the final minutes of trading on Tuesday, shares hit $171.94, a rise of slightly more than 5 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on AMGN at https://www.zacks.com/ap/AMGN", "external_links": [], "published": "2018-04-25T00:55:00.000+03:00", "crawled": "2018-04-25T06:55:47.026+03:00", "highlightTitle": ""}